Pronađeno: 1-2 / 2 radova

Autori: Sreckovic Slobodan

>> Prikaži sve rezultate

Naslov Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) (Article)
Autori Colombel Jean Frederic  ...  Sreckovic Slobodan  ...  (broj koautora 33) 
Info JOURNAL OF CROHNS & COLITIS, (2025), vol. 19 br. 6, str. -
Projekat Celltrion, Inc; Celltrion, Inc. (Incheon, Republic of Korea)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY) (Article; Proceedings Paper)
Autori Hanauer Stephen B  ...  Sreckovic Slobodan  ...  (broj koautora 33) 
Info GASTROENTEROLOGY, (2024), vol. 167 br. 5, str. 919-933
Projekat Celltrion, Inc (Incheon, Republic Korea)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX